Maude Ardin

2.2k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Maude Ardin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Maude Ardin has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Maude Ardin's work include Cancer Genomics and Diagnostics (9 papers), Epigenetics and DNA Methylation (3 papers) and Single-cell and spatial transcriptomics (2 papers). Maude Ardin is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Epigenetics and DNA Methylation (3 papers) and Single-cell and spatial transcriptomics (2 papers). Maude Ardin collaborates with scholars based in France, United Kingdom and United States. Maude Ardin's co-authors include Jiří Zavadil, Magali Olivier, Monica Hollstein, Graham Byrnes, Liacine Bouaoun, Dmitriy Sonkin, Xavier Castells, Ludmil B. Alexandrov, Christopher P. Wild and Stéphanie Villar and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Maude Ardin

18 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

2016 536 citations Liacine Bouaoun, Dmitriy Sonkin et al. Human Mutation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maude Ardin France	11	542	446	393	123	96	19	1.1k
Xuan Bich Trinh Belgium	22	618 1.1×	533 1.2×	380 1.0×	108 0.9×	117 1.2×	39	1.4k
Danhui Weng China	22	926 1.7×	492 1.1×	471 1.2×	147 1.2×	113 1.2×	41	1.5k
Adrian Wan Canada	12	630 1.2×	245 0.5×	556 1.4×	122 1.0×	166 1.7×	13	1.2k
Wen-Shin Chang Taiwan	19	427 0.8×	299 0.7×	456 1.2×	43 0.3×	75 0.8×	72	989
Susan Colman United Kingdom	11	540 1.0×	310 0.7×	391 1.0×	125 1.0×	70 0.7×	12	1.3k
Weihong Zhao China	19	692 1.3×	214 0.5×	389 1.0×	133 1.1×	44 0.5×	68	1.1k
Zhihui Feng China	20	1.6k 2.9×	650 1.5×	466 1.2×	204 1.7×	65 0.7×	39	1.9k
Ming-hua Zhu China	21	833 1.5×	289 0.6×	461 1.2×	47 0.4×	105 1.1×	50	1.2k
Xiao Qi Wang Hong Kong	22	1.1k 2.0×	629 1.4×	394 1.0×	41 0.3×	93 1.0×	33	1.5k
Ryouichi Tsunedomi Japan	22	671 1.2×	610 1.4×	335 0.9×	118 1.0×	77 0.8×	64	1.3k

Countries citing papers authored by Maude Ardin

Since Specialization

Citations

This map shows the geographic impact of Maude Ardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maude Ardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maude Ardin more than expected).

Fields of papers citing papers by Maude Ardin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maude Ardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maude Ardin. The network helps show where Maude Ardin may publish in the future.

Co-authorship network of co-authors of Maude Ardin

This figure shows the co-authorship network connecting the top 25 collaborators of Maude Ardin. A scholar is included among the top collaborators of Maude Ardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maude Ardin. Maude Ardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Rodriguez, Céline, Maude Ardin, Anne‐Claire Doffin, et al.. (2025). Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2. Nature Communications. 16(1). 3045–3045. 5 indexed citations

2.

Collet, L., J.C. Noël, Maude Ardin, et al.. (2025). Tumor–stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial. ESMO Open. 10(6). 105104–105104.

3.

Cockenpot, Vincent, Cyril Dégletagne, Roxane M. Pommier, et al.. (2023). Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes. Laboratory Investigation. 103(12). 100258–100258. 10 indexed citations

4.

Lecot, Pacôme, Maude Ardin, Sébastien Dussurgey, et al.. (2022). Gene signature of circulating platelet‐bound neutrophils is associated with poor prognosis in cancer patients. International Journal of Cancer. 151(1). 138–152. 16 indexed citations

5.

Karanović, Sandra, Maude Ardin, Zuojian Tang, et al.. (2021). Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure. International Journal of Cancer. 150(2). 374–386. 8 indexed citations

6.

Ramos, Rodrigo Nalio, Margaux Hubert, Maude Ardin, et al.. (2020). CD163⁺ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes. Clinical & Translational Immunology. 9(2). e1108–e1108. 54 indexed citations

7.

Ng, Alvin Wei Tian, Maude Ardin, Mona I. Churchwell, et al.. (2019). Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans. Genome Research. 29(4). 521–531. 59 indexed citations

8.

Tomková, Markéta, Claire Renard, Lara Urban, et al.. (2019). Abstract 4661: Deciphering the causes of the COSMIC mutational signature 17 by combining pan-cancer data with experimental mouse models. Tumor Biology. 4661–4661. 1 indexed citations

9.

Tomková, Markéta, Claire Renard, Lara Urban, et al.. (2019). Abstract 4661: Deciphering the causes of the COSMIC mutational signature 17 by combining pan-cancer data with experimental mouse models. Cancer Research. 79(13_Supplement). 4661–4661. 2 indexed citations

10.

Viarisio, Daniele, Karin Müller‐Decker, Rosita Accardi, et al.. (2018). Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice. PLoS Pathogens. 14(1). e1006783–e1006783. 83 indexed citations

11.

Ardin, Maude, Annette Weninger, Sarah Barrin, et al.. (2017). Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing. Oncogene. 36(43). 6041–6048. 8 indexed citations

12.

Huang, Mi, Willie Yu, Maude Ardin, et al.. (2017). Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors. Genome Research. 27(9). 1475–1486. 75 indexed citations

13.

Ardin, Maude, Vincent Cahais, Xavier Castells, et al.. (2016). MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes. BMC Bioinformatics. 17(1). 170–170. 29 indexed citations

14.

Hollstein, Monica, Ludmil B. Alexandrov, Christopher P. Wild, Maude Ardin, & Jiří Zavadil. (2016). Base changes in tumour DNA have the power to reveal the causes and evolution of cancer. Oncogene. 36(2). 158–167. 46 indexed citations

15.

Bouaoun, Liacine, Dmitriy Sonkin, Maude Ardin, et al.. (2016). TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data. Human Mutation. 37(9). 865–876. 536 indexed citations breakdown →

16.

Olivier, Magali, Liacine Bouaoun, Dmitriy Sonkin, et al.. (2016). TP53 variations in human cancers: new lessons from the IARC TP53 Database and genomic studies. European Journal of Cancer. 61. S15–S15. 3 indexed citations

17.

Vaca‐Paniagua, Felipe, Rosa María Álvarez-Gómez, Héctor Aquiles Maldonado-Martínez, et al.. (2015). Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues. PLoS ONE. 10(5). e0126762–e0126762. 16 indexed citations

18.

Olivier, Magali, Annette Weninger, Maude Ardin, et al.. (2014). Modelling mutational landscapes of human cancers in vitro. Scientific Reports. 4(1). 4482–4482. 68 indexed citations

19.

Jelaković, Bojan, Xavier Castells, Karla Tomić, et al.. (2014). Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid. International Journal of Cancer. 136(12). 2967–2972. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact